These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2075700)

  • 1. [The effect of the oxime HI-6 on miosis induced by topical administration of sarin and VX in the rabbit eye].
    Macić I; Vojvodić V; Knezević D; Maksimović M
    Vojnosanit Pregl; 1990; 47(6):399-401. PubMed ID: 2075700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
    Maxwell DM; Koplovitz I; Worek F; Sweeney RE
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig.
    Wilhelm CM; Snider TH; Babin MC; Platoff GE; Jett DA; Yeung DT
    Neurotoxicology; 2018 Sep; 68():142-148. PubMed ID: 30056178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism Between Anticholinergic and Oxime Treatments Against Sarin-Induced Ocular Insult in Rats.
    Gore A; Brandeis R; Egoz I; Turetz J; Nili U; Grauer E; Bloch-Shilderman E
    Toxicol Sci; 2015 Aug; 146(2):301-10. PubMed ID: 25956921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface histopathological insult following sarin and VX exposure and potential treatments in the rat model.
    Gore A; Lazar S; Yacov G; Gez R; Rabinowitz I; Nili U; Egoz I; Kadar T
    Toxicol Lett; 2019 Oct; 314():153-163. PubMed ID: 31408696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro.
    Becker G; Kawan A; Gutzeit D; Worek F; Szinicz L
    Arch Toxicol; 2007 Jun; 81(6):415-20. PubMed ID: 17151865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atropine and the oxime HI-6 on low-level sarin-induced alteration of performance of rats in a T-maze.
    Krejcová G; Kassa J; Vachek J
    Acta Medica (Hradec Kralove); 2002; 45(3):107-10. PubMed ID: 12515047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime.
    Puu G; Artursson E; Bucht G
    Biochem Pharmacol; 1986 May; 35(9):1505-10. PubMed ID: 3518721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel centrally active oxime reactivators of acetylcholinesterase inhibited by surrogates of sarin and VX.
    Chambers JE; Meek EC
    Neurobiol Dis; 2020 Jan; 133():104487. PubMed ID: 31158460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection From Organophosphate-Induced Damage by Novel Phenoxyalkyl Pyridinium Oximes in Rat Brain.
    Pringle RB; Meek EC; Chambers HW; Chambers JE
    Toxicol Sci; 2018 Dec; 166(2):420-427. PubMed ID: 30496567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.
    Gore A; Bloch-Shilderman E; Egoz I; Turetz J; Brandeis R
    Br J Pharmacol; 2014 May; 171(9):2364-74. PubMed ID: 24428128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers.
    Acharya J; Dubey DK; Srivastava AK; Raza SK
    Toxicol In Vitro; 2011 Feb; 25(1):251-6. PubMed ID: 20688148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
    Chambers JE; Meek EC; Chambers HW
    Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
    Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
    Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
    Kassa J; Misik J; Karasova JZ
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.